Literature DB >> 14684954

A case of acute generalized exanthematous pustulosis (AGEP) possibly induced by iohexol.

Mustafa Atasoy1, Teoman Erdem, Refik Ali Sari.   

Abstract

Acute generalized exanthematous pustulosis (AGEP) is an uncommon disease manifested as an erythematous pustular eruption. It is usually caused by systemic medication. We describe a patient with acute generalized pustular eruption induced by iohexol. A 52-year-old woman developed fever and a generalized pustular eruption on the neck, trunk and extremities three days after taking iohexol. The culture from pustules was sterile. Other systemic and laboratory examinations were normal. A skin biopsy from a lesion on the trunk showed the features of a drug-induced pustular eruption as a subcorneal blister including neutrophils and eosinophils, mild spongiosis, and a sparse infiltrate at neutrophils and eosinophils in the papillary dermis. The patient had no history of psoriasis. The lesions resolved with systemic corticosteroid therapy within one week and did not relapse. According to our investigation, iohexol-induced AGEP has not been previously reported. We present an interesting case.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14684954     DOI: 10.1111/j.1346-8138.2003.tb00466.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  2 in total

1.  Clinicopathologic manifestations of 36 korean patients with acute generalized exanthematous pustulosis: a case series and review of the literature.

Authors:  Min Jee Choi; Hei Sung Kim; Hyun Jeong Park; Chul Jong Park; Jeong Deuk Lee; Jun Young Lee; Hyung Ok Kim; Young Min Park
Journal:  Ann Dermatol       Date:  2010-05-17       Impact factor: 1.444

Review 2.  Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients.

Authors:  Enriqueta Vallejo-Yagüe; Adrian Martinez-De la Torre; Omar S Mohamad; Shweta Sabu; Andrea M Burden
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.